IRIS-BioFreedom Cohort in the IRIS-DES Registry (IRISBioFreedom)

Seung-Jung Park

Status: Enrolling

Conditions: Coronary Stenosis

Treatments: Device: BIOFREEDOM™ FAMILY stent

Study type: Observational

Funder types: Other

Identifiers

NCT03190057

AMCCV2017-04

Details and patient eligibility

About

The objective of this study is to evaluate effectiveness and safety of BIOFREEDOM™ FAMILY stent in the "real world" daily practice as compared with other drug-eluting stents.

Full description

BIOFREEDOM™ FAMILY stent means that Biofreedom stent, Biofreedom Ultra and the other stents with names starting with Biofreedom.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 19 and more
• Patient with BIOFREEDOM™ FAMILY stent
• Written consent

Exclusion criteria

• Intervention with BIOFREEDOM™ FAMILY stent and other drug eluting stent at the same time
• Life-expectancy less than 1 year
• Cardiac shock

Trial design

1,000 participants in 1 patient group

Consecutive percutaneous coronary intervention

Treatment:

Device: BIOFREEDOM™ FAMILY stent